A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the radiation therapy oncology group (RTOG) 9104
- 1 October 1997
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 39 (3) , 571-574
- https://doi.org/10.1016/s0360-3016(97)00341-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28International Journal of Radiation Oncology*Biology*Physics, 1993
- Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater results of radiation therapy oncology group 85–28Cancer, 1993
- Different Fractionation Schedules in Radiation Treatment of Cerebral MetastasesActa Radiologica: Oncology, 1986
- Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1981
- The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1980
- A Qualitative Discrepancy between Censored Data Rank TestsBiometrics, 1979